RESEARCH AND INNOVATION
Advancing sciencethrough research and innovation
Our company collaborates with world-leading experts to accelerate the translation of innovative technologies to support clinical management across the spectrum of disease, from metabolic disorders such as NAFLD and diabetes, to cancer.
Introducing CoverScan
The product of our latest research is CoverScan, a noninvasive imaging tool to assess the health of six organs using a single scan. We developed this product over a two-year journey working alongside our long COVID study community participants.
This work has enabled us to assess multi-organ impairment in patients affected by long COVID and other conditions, whilst also investigating the inequalities in access and provision of high-quality long COVID care.
Perspectum’s Prof. Sir Mike Brady and Dr. Rajarshi Banerjee are team members of the largest long COVID clinical study to-date — STIMULATE-ICP — led by University College London Hospitals NHS Trust and University College London, together with researchers, health professionals, patients, and industry partners from over 30 organizations.
Explore our research and innovation initiatives
Publications
Explore our library of peer-reviewed clinical evidence, including our landmark paper on mpMRI as a predictive tool for clinical outcomes.
Learn more
Research projects
Explore our innovative solutions to the problems facing the healthcare sector and their patients.
Learn more
Recent Publications
Explore our library of peer-reviewed clinical evidence, including the recent publication in Open Heart, "Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection".